Skip to main content


Genitourinary Cancer

Sandeep Voleti, BS, discusses a study evaluating monetary trends in Medicare reimbursement for radical hysterectomy and…
Dana Chase, MD, FACOG, Arizona Oncology, discusses patient-reported outcomes in patients receiving niraparib on the…
David Cella, PhD, Northwestern University, discusses results from a phase 3 study examining HRQoL in patients with…
Richard Penson, MD, MRCP, discusses the results from the SOLO2 study assessing maintenance olaparib in patients with…
Thomas Krivak, MD, considers PARP inhibitors and their role in pathways and standardized care in the maintenance and…
JCP spoke with Thomas Krivak, MD, at the Clinical Pathways Congress (October 26-28, 2018; Boston, MA) about the many…
Back to Top